Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-25 4:36 pm Purchase |
2024-03-19 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,749,015 5.500% |
736,732 (+14.70%) |
Filing History |
| 2024-03-07 4:25 pm Purchase |
2024-02-26 | 13G | TPG Inc. TPG |
Integrated Core Strategies (US) LLC | 3,361,369 3.600% |
3,361,369 (New Position) |
Filing History |
| 2024-02-15 4:17 pm Purchase |
2024-02-09 | 13G | Helix Acquisition Corp. II HLXB |
Integrated Core Strategies (US) LLC | 1,100,000 5.800% |
1,100,000 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Plum Acquisition Corp. III PLMJ |
Integrated Core Strategies (US) LLC | 1,324,566 8.500% |
-1,150,434 (-46.48%) |
Filing History |
| 2024-02-12 4:35 pm Purchase |
2023-12-31 | 13G | United Homes Group, Inc. UHG |
Integrated Core Strategies (US) LLC | 208,963 1.800% |
208,963 (New Position) |
Filing History |
| 2024-02-12 4:24 pm Sale |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Integrated Core Strategies (US) LLC | 0 0.000% |
-5,555,085 (Position Closed) |
Filing History |
| 2024-02-09 4:11 pm Purchase |
2024-01-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Integrated Core Strategies (US) LLC | 419,707 4.100% |
419,707 (New Position) |
Filing History |
| 2024-02-08 4:43 pm Purchase |
2023-12-31 | 13G | Vapotherm, Inc. VAPO |
Integrated Core Strategies (US) LLC | 490,044 7.800% |
490,044 (New Position) |
Filing History |
| 2024-02-08 4:36 pm Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Integrated Core Strategies (US) LLC | 108,486 0.300% |
108,486 (New Position) |
Filing History |
| 2024-02-06 4:20 pm Sale |
2023-12-31 | 13G | CUTERA INC CUTRQ |
Integrated Core Strategies (US) LLC | 827,032 4.100% |
-663,040 (-44.50%) |
Filing History |
| 2024-02-05 4:32 pm Purchase |
2023-12-31 | 13G | flyExclusive, Inc. FLYX |
Integrated Core Strategies (US) LLC | 37,500 0.200% |
37,500 (New Position) |
Filing History |
| 2024-02-05 4:27 pm Purchase |
2023-12-31 | 13G | Longevity Health Holdings Inc. XAGE |
Integrated Core Strategies (US) LLC | 235,414 1.000% |
235,414 (New Position) |
Filing History |
| 2024-02-01 4:25 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,012,283 4.800% |
-758,611 (-13.15%) |
Filing History |
| 2024-01-31 4:32 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 2,990,279 7.100% |
1,592,897 (+113.99%) |
Filing History |
| 2024-01-30 4:25 pm Sale |
2023-12-31 | 13G | TKB Critical Technologies 1 USCT |
Integrated Core Strategies (US) LLC | 0 0.000% |
-992,538 (Position Closed) |
Filing History |
| 2024-01-29 4:42 pm Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 1,730,889 5.200% |
-464,140 (-21.15%) |
Filing History |
| 2024-01-29 4:36 pm Sale |
2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Integrated Core Strategies (US) LLC | 132,674 4.900% |
-1,029 (-0.77%) |
Filing History |
| 2024-01-26 4:19 pm Sale |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Integrated Core Strategies (US) LLC | 6,610 0.000% |
-981,102 (-99.33%) |
Filing History |
| 2024-01-25 4:09 pm Purchase |
2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN |
Integrated Core Strategies (US) LLC | 3,479,630 5.600% |
3,479,630 (New Position) |
Filing History |
| 2024-01-24 4:16 pm Sale |
2023-12-31 | 13G | BioLife Solutions, Inc. BLFS |
Integrated Core Strategies (US) LLC | 2,412,650 5.400% |
-69,296 (-2.79%) |
Filing History |